What Are Peptides? A Peptides 101 Guide to What Changed and What Comes Next

Peptides cover a lot of ground, from established prescription medicines to compounds with far more questions than answers. If you’re exploring them for a health goal, start by understanding the difference. What are peptides, what does the recent HHS policy change, and what should you ask before considering treatment? This Peptides 101 guide covers all three.

The Short Answer

Peptides are short chains of amino acids, and your body makes thousands of them. Some are well-established medicines, like insulin and GLP-1 medications. In wellness circles, “peptides” often means newer compounds such as BPC-157. HHS recently announced an interim policy describing when it doesn’t intend to take enforcement action against qualifying compounders using six of them. That isn’t FDA approval, so a licensed provider and pharmacy still matter.

What to Know

• Peptides are short chains of amino acids that often act as messengers in the body.

• GLP-1 medications such as semaglutide and tirzepatide are peptides, and so is insulin.

• A new HHS interim policy covers six peptides: BPC-157, Epitalon, KPV, MOTS-c, Semax, and TB-500. It isn’t FDA approval.

• Research-use-only products mixed at home are very different from peptides prepared by a licensed pharmacy.

• Human research on the six newer peptides is limited, so realistic expectations and provider guidance are essential.

WEIGHT MANAGEMENT

Your weight goals, with a provider in your corner

Curious whether GLP-1 treatment fits your goals? See how it works and what to expect.

Learn More

What Are Peptides, Exactly?

A peptide is a short chain of amino acids, the same building blocks that make up proteins. If proteins are full sentences, peptides are short phrases. Many of them work as signals, telling cells when to release a hormone, repair tissue, or adjust how the body uses energy.

You already know more peptides than you might think. Insulin is a peptide hormone. GLP-1 medications are peptides too: semaglutide acts on GLP-1 receptors, while tirzepatide acts on both GLP-1 and GIP receptors. Sermorelin is a lab-made peptide modeled on part of a hormone that signals the pituitary gland. So peptides aren’t a fringe category. They’re a big family that includes some of the most widely used medicines today.

Why Peptides Are Having a Moment

Interest in peptides has grown alongside interest in recovery, energy, and healthy aging. When people talk about “peptides” online right now, they usually mean a handful of emerging compounds, not insulin or GLP-1s. This guide focuses on the six covered by the new HHS policy: BPC-157, Epitalon, KPV, MOTS-c, Semax, and TB-500.

Those six previously sat in the FDA’s Category 2, a list of bulk substances flagged for potential significant safety risks in compounding. They were removed from that list in April 2026, but removal didn’t, by itself, authorize compounding. Research-use-only powders sold online raise a separate concern: they are not intended for patient treatment.

What Changed: The HHS Interim Peptide Policy

The U.S. Department of Health and Human Services (HHS) has announced a draft, interim enforcement-discretion policy covering those six peptides. In plain terms, while the FDA works through formal rulemaking, HHS describes circumstances in which it doesn’t intend to take enforcement action against qualifying compounding pharmacies that use them.

Precision matters here, because the headlines don’t always get it right. HHS has said part of its goal is to steer people away from research-use-only products and toward a more controlled path. Here’s what the policy does and doesn’t do.

Research-Use-Only vs. Pharmacy-Prepared: Know the Difference

Products labeled “for research use only” or “not for human consumption” aren’t meant for patient treatment. A purity report or polished packaging doesn’t change that. Some sellers supply powders that buyers attempt to prepare and measure themselves, adding preparation and dosing risks.

Home mixing turns you into the pharmacist. Professional preparation can reduce avoidable risks, but safe handling and accurate dose measurement still matter at home.

If you’re exploring peptides, here’s what a more trustworthy path tends to include:

• A licensed provider who reviews your health history and goals before anything is prescribed

• An identifiable, licensed pharmacy that prepares the medication and can answer your questions

• Documented sourcing and quality checks for the ingredients

• Clear instructions and follow-up, including how to store it and how to report a problem

• An honest conversation about the evidence, including what isn’t known yet

What Are Peptides Used For? What the Evidence Says

Established peptide medicines, like GLP-1s and insulin, have been studied extensively for their approved uses. Evidence supporting an FDA-approved medication does not establish the safety, effectiveness, or quality of a compounded preparation containing the same active ingredient. The six newer peptides are a different story. You may have seen bold claims about recovery, energy, focus, or longevity, but human research on all six is limited, and none is FDA-approved for any condition.

Interest is a starting point. Evidence should guide the decision. Treat these compounds as open questions, not shortcuts. Benefits, side effects, interactions, dosing, and long-term safety all still need better answers. A provider can help you weigh what’s known against your own health picture and goals.

How to Explore Peptides the Smart Way

1. Define the goal first. Then ask which options have evidence relevant to it.

2. Talk with a licensed provider. They can review your history, medications, and goals, and tell you whether a peptide makes sense at all.

3. Ask who prepares it. Look for a state-licensed pharmacy and clear sourcing information.

4. Skip research-use-only products. Labels and lab reports from online sellers don’t make a product suitable for human use.

5. Set realistic expectations. Plan for follow-up, and keep track of how you feel and any side effects.

10Rx connects you with licensed providers for provider-guided treatment options designed to fit real schedules, including GLP-1 medications and sermorelin. Your provider can help you sort out which options, if any, match your goals.

Questions to Ask Your Provider About Peptides

• Is a peptide a reasonable option for my goals, or is there a better-studied approach?

• Who prepares this medication, and is it a state-licensed pharmacy?

• What does the research actually show, and what’s still unknown?

• Could this interact with my current medications or health conditions?

• What side effects should I watch for, and how do I report a problem?

• How will we check in on my progress?

Peptides FAQ

Are GLP-1 medications peptides?

Yes. GLP-1 medications such as semaglutide and tirzepatide are peptides: short chains of amino acids that act on specific receptors in the body. They’re a good reminder that peptides are a broad family. The six compounds in the news right now are a separate group, and none of them is FDA-approved.

Are peptides FDA-approved?

Some are. Several peptide medications, including insulin and FDA-approved GLP-1 medications, have gone through the FDA’s approval process. The six peptides covered by HHS’s interim policy have not. Compounded versions prepared under the policy aren’t FDA-approved either, which means the FDA hasn’t reviewed them for safety, effectiveness, or quality.

What does “research use only” mean?

“Research use only” means the product is not intended for patient treatment. A purity report or professional packaging does not establish that it is suitable for human use. HHS cited the safety risks of these products as one reason for its interim policy.

Is sermorelin a peptide?

Yes. Sermorelin is a lab-made peptide based on part of growth hormone–releasing hormone, which signals the pituitary gland. It isn’t one of the six peptides covered by the HHS policy. It’s a prescription medication, so a licensed provider evaluates whether it’s appropriate for you.

The Bottom Line

Peptides are a big, useful family of molecules, and the ones in the headlines just went through a meaningful policy shift. That shift isn’t FDA approval, and it doesn’t make every peptide product trustworthy.

Your next step is a better-informed conversation. Define your goal, ask what the evidence supports, and understand who would prepare and monitor any treatment. A licensed provider can help you compare options, including whether a better-studied approach makes more sense.

WEIGHT MANAGEMENT

Your weight goals, with a provider in your corner

Curious whether GLP-1 treatment fits your goals? See how it works and what to expect.

Learn More

Sources and References

• HHS Enforcement Discretion Policy Regarding 503A Compounding Using Certain Peptide Bulk Drug Substances. U.S. Department of Health and Human Services.

• Federal Register Notice on the Interim Peptide Compounding Policy. Federal Register, October 30, 2026.

• Certain Bulk Drug Substances for Use in Compounding That May Present Significant Safety Risks. U.S. Food and Drug Administration.

• Human Drug Compounding. U.S. Food and Drug Administration.

Last reviewed: November 2026

Disclaimer: This article is for general educational purposes and is not medical advice. Compounded medications are not FDA-approved. Talk with a licensed healthcare provider about your individual needs before starting, stopping, or changing any treatment.